Todd M Gibson1, Wei Liu2, Gregory T Armstrong1,3, Deo Kumar Srivastava2, Melissa M Hudson1,3, Wendy M Leisenring4, Ann C Mertens5, Robert C Klesges1,6, Kevin C Oeffinger7, Paul C Nathan8, Leslie L Robison1. 1. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee. 3. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. 4. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 5. Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia. 6. Center for Population Sciences, Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee. 7. Department of Medicine and Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. 8. Department of Pediatrics, Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada.
Abstract
BACKGROUND: Survivors of pediatric cancer have elevated risks of mortality and morbidity. Many late adverse effects associated with cancer treatment (eg, second cancers and cardiac and pulmonary disease) are also associated with cigarette smoking, and this suggests that survivors who smoke may be at high risk for these conditions. METHODS: This study examined the self-reported smoking status for 9397 adult survivors of childhood cancer across 3 questionnaires (median time interval, 13 years). The smoking prevalence among survivors was compared with the smoking prevalence among siblings and the prevalence expected on the basis of age-, sex-, race-, and calendar time-specific rates in the US population. Multivariable regression models examined characteristics associated with longitudinal smoking patterns across all 3 questionnaires. RESULTS: At the baseline, 19% of survivors were current smokers, whereas 24% of siblings were current smokers, and 29% were expected to be current smokers on the basis of US rates. Current smoking among survivors dropped to 16% and 14% on follow-up questionnaires, with similar decreases in the sibling prevalence and the expected prevalence. Characteristics associated with consistent never-smoking included a higher household income (relative risk [RR], 1.16; 95% confidence interval [CI], 1.08-1.25), higher education (RR, 1.32; 95% CI, 1.22-1.43), and receipt of cranial radiation therapy (RR, 1.08; 95% CI, 1.03-1.14). Psychological distress (RR, 0.86; 95% CI, 0.80-0.92) and heavy alcohol drinking (RR, 0.64; 95% CI, 0.58-0.71) were inversely associated. Among ever-smokers, a higher income (RR, 1.17; 95% CI, 1.04-1.32) and education (RR, 1.23; 95% CI, 1.10-1.38) were associated with quitting, whereas cranial radiation (RR, 0.86; 95% CI, 0.76-0.97) and psychological distress (RR, 0.80; 95% CI, 0.72-0.90) were associated with not having quit. The development of adverse health conditions was not associated with smoking patterns. CONCLUSIONS: Despite modest declines in smoking prevalence, the substantial number of consistent current smokers reinforces the need for continued development of effective smoking interventions for survivors.
BACKGROUND: Survivors of pediatric cancer have elevated risks of mortality and morbidity. Many late adverse effects associated with cancer treatment (eg, second cancers and cardiac and pulmonary disease) are also associated with cigarette smoking, and this suggests that survivors who smoke may be at high risk for these conditions. METHODS: This study examined the self-reported smoking status for 9397 adult survivors of childhood cancer across 3 questionnaires (median time interval, 13 years). The smoking prevalence among survivors was compared with the smoking prevalence among siblings and the prevalence expected on the basis of age-, sex-, race-, and calendar time-specific rates in the US population. Multivariable regression models examined characteristics associated with longitudinal smoking patterns across all 3 questionnaires. RESULTS: At the baseline, 19% of survivors were current smokers, whereas 24% of siblings were current smokers, and 29% were expected to be current smokers on the basis of US rates. Current smoking among survivors dropped to 16% and 14% on follow-up questionnaires, with similar decreases in the sibling prevalence and the expected prevalence. Characteristics associated with consistent never-smoking included a higher household income (relative risk [RR], 1.16; 95% confidence interval [CI], 1.08-1.25), higher education (RR, 1.32; 95% CI, 1.22-1.43), and receipt of cranial radiation therapy (RR, 1.08; 95% CI, 1.03-1.14). Psychological distress (RR, 0.86; 95% CI, 0.80-0.92) and heavy alcohol drinking (RR, 0.64; 95% CI, 0.58-0.71) were inversely associated. Among ever-smokers, a higher income (RR, 1.17; 95% CI, 1.04-1.32) and education (RR, 1.23; 95% CI, 1.10-1.38) were associated with quitting, whereas cranial radiation (RR, 0.86; 95% CI, 0.76-0.97) and psychological distress (RR, 0.80; 95% CI, 0.72-0.90) were associated with not having quit. The development of adverse health conditions was not associated with smoking patterns. CONCLUSIONS: Despite modest declines in smoking prevalence, the substantial number of consistent current smokers reinforces the need for continued development of effective smoking interventions for survivors.
Authors: R Haupt; J Byrne; R R Connelly; E N Mostow; D F Austin; G R Holmes; F F Holmes; H B Latourette; M J Teta; L C Strong Journal: Med Pediatr Oncol Date: 1992
Authors: Ann C Mertens; Yutaka Yasui; Yan Liu; Marilyn Stovall; Ray Hutchinson; Jill Ginsberg; Charles Sklar; Leslie L Robison Journal: Cancer Date: 2002-12-01 Impact factor: 6.921
Authors: Karen Emmons; Frederick P Li; John Whitton; Ann C Mertens; Raymond Hutchinson; Lisa Diller; Leslie L Robison Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 50.717
Authors: Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: Med Pediatr Oncol Date: 2002-04
Authors: Karen M Emmons; Rita M Butterfield; Elaine Puleo; Elyse R Park; Ann Mertens; Ellen R Gritz; Maureen Lahti; Fredrick P Li Journal: J Clin Oncol Date: 2003-01-15 Impact factor: 50.717
Authors: I-Chan Huang; James L Klosky; Chelsea M Young; Sharon E Murphy; Kevin K Krull; DeoKumar Srivastava; Melissa M Hudson; Leslie L Robison Journal: Pediatr Blood Cancer Date: 2018-06-01 Impact factor: 3.167
Authors: Tara M Brinkman; Christopher J Recklitis; Gisela Michel; Martha A Grootenhuis; James L Klosky Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Eric J Chow; Yan Chen; Gregory T Armstrong; Laura-Mae Baldwin; Casey R Cai; Todd M Gibson; Melissa M Hudson; Aaron McDonald; Paul C Nathan; Jeffrey E Olgin; Karen L Syrjala; Emily S Tonorezos; Kevin C Oeffinger; Yutaka Yasui Journal: J Am Heart Assoc Date: 2022-06-08 Impact factor: 6.106
Authors: Taumoha Ghosh; Yan Chen; Andrew C Dietz; Gregory T Armstrong; Rebecca M Howell; Susan A Smith; Daniel A Mulrooney; Lucie M Turcotte; Yan Yuan; Yutaka Yasui; Joseph P Neglia Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-09-14 Impact factor: 4.090
Authors: Stephanie B Dixon; Kari L Bjornard; Nicole M Alberts; Gregory T Armstrong; Tara M Brinkman; Wassim Chemaitilly; Matthew J Ehrhardt; Israel Fernandez-Pineda; Lisa M Force; Todd M Gibson; Daniel M Green; Carrie R Howell; Sue C Kaste; Anne C Kirchhoff; James L Klosky; Kevin R Krull; John T Lucas; Daniel A Mulrooney; Kirsten K Ness; Carmen L Wilson; Yutaka Yasui; Leslie L Robison; Melissa M Hudson Journal: CA Cancer J Clin Date: 2018-01-29 Impact factor: 508.702